{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T11:49:29Z","timestamp":1790250569137,"version":"4.1.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,8,13]],"date-time":"2018-08-13T00:00:00Z","timestamp":1534118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,8,13]],"date-time":"2018-08-13T00:00:00Z","timestamp":1534118400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>In Peru, hepatocellular carcinoma (HCC) arises in young non-cirrhotic patients. Hepatitis B virus (HBV) is suspected to be the prominent etiological agent. We thus performed a comprehensive molecular study of HBV infection in 65 Peruvian HCC patients. Only 51% were considered as persistently infected at the onset. HBV DNA was found by PCR in the tumor and\/or matched non-tumor liver tissues in more than 80% of cases (n\u2009=\u200953\/65). HBV DNA was significantly more abundant in livers of younger patients than in those of the older ones. We consistently observed low viral DNA burden (0.1\u20136.5 copies for 100 cells), with viral genomes in younger patients displaying higher proportion of mutations at di-pyrimidines (TpT and CpC, P\u2009=\u20090.006). A drastic activation of multiple DNA repair pathways in tumors of younger patients was observed. Our observations clearly challenge the current vision that associates high HBV DNA load with earlier tumor development. We concluded that in Peru, and maybe in other populations with Americas\u2019 indigenous ancestry, HBV-associated liver tumorigenesis might differ significantly from that generally observed in the rest of the world. Procedures used to screen for HCC development in subjects at risk should be adapted to the local situation.<\/jats:p>","DOI":"10.1038\/s41598-018-30229-8","type":"journal-article","created":{"date-parts":[[2018,8,7]],"date-time":"2018-08-07T10:48:54Z","timestamp":1533638934000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Early-onset liver cancer in South America associates with low hepatitis B virus DNA burden"],"prefix":"10.1038","volume":"8","author":[{"given":"Agn\u00e8s","family":"Marchio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3032-3180","authenticated-orcid":false,"given":"Juan Pablo","family":"Cerapio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eloy","family":"Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3417-8750","authenticated-orcid":false,"given":"Luis","family":"Cano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8406-739X","authenticated-orcid":false,"given":"Sandro","family":"Casavilca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beno\u00eet","family":"Terris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Deharo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Dejean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0398-9745","authenticated-orcid":false,"given":"St\u00e9phane","family":"Bertani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Pineau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,8,13]]},"reference":[{"key":"30229_CR1","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/S1470-2045(12)70211-5","volume":"13","author":"F Bray","year":"2012","unstructured":"Bray, F., Jemal, A., Grey, N., Ferlay, J. & Forman, D. Global cancer transitions according to the Human Development Index (2008-2030): a population-based study. Lancet Oncol 13, 790\u2013801 (2012).","journal-title":"Lancet Oncol"},{"key":"30229_CR2","unstructured":"Cancer today, https:\/\/gco.iarc.fr\/today\/home (2018)."},{"key":"30229_CR3","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S1665-2681(19)31681-3","volume":"9","author":"E Fassio","year":"2010","unstructured":"Fassio, E. et al. Etiology of hepatocellular carcinoma in Latin America: a prospective, multicenter, international study. Ann Hepatol. 9, 63\u201369 (2010).","journal-title":"Ann Hepatol."},{"key":"30229_CR4","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1002\/hep.27969","volume":"62","author":"C de Martel","year":"2015","unstructured":"de Martel, C., Maucort-Boulch, D., Plummer, M. & Franceschi, S. World-wide relative contribution of hepatitis B and C viruses in hepatocellular carcinoma. Hepatology 62, 1190\u20131200 (2015).","journal-title":"Hepatology"},{"key":"30229_CR5","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/j.jhep.2009.10.033","volume":"52","author":"C Neuveut","year":"2010","unstructured":"Neuveut, C., Wei, Y. & Buendia, M. Mechanisms of HBV-related hepatocarcinogenesis. J Hepatol 52, 594\u2013604 (2010).","journal-title":"J Hepatol"},{"key":"30229_CR6","doi-asserted-by":"publisher","first-page":"S130","DOI":"10.1016\/S1386-6532(05)80022-8","volume":"37","author":"R Parana","year":"2005","unstructured":"Parana, R. & Almeida, D. HBV epidemiology in Latin America. J Clin Virol 37, S130\u2013133 (2005).","journal-title":"J Clin Virol"},{"key":"30229_CR7","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1093\/infdis\/174.5.920","volume":"174","author":"J Casey","year":"1996","unstructured":"Casey, J. et al. Hepatitis B virus (HBV)\/hepatitis D virus (HDV) coinfection in outbreaks of acute hepatitis in the Peruvian Amazon basin: the roles of HDV genotype III and HBV genotype F. J Infect Dis. 174, 920\u2013926 (1996).","journal-title":"J Infect Dis."},{"key":"30229_CR8","first-page":"96","volume":"25","author":"C Cabezas","year":"2008","unstructured":"Cabezas, C. Situation and control of Hepatitis B and Delta in Peru. Acta Med Per 25, 96\u2013112 (2008).","journal-title":"Acta Med Per"},{"key":"30229_CR9","doi-asserted-by":"publisher","first-page":"e67756","DOI":"10.1371\/journal.pone.0067756","volume":"8","author":"S Bertani","year":"2013","unstructured":"Bertani, S. et al. An atypical age-specific pattern of hepatocellular carcinoma in Peru: a threat for Andean populations. PLoS One 8, e67756 (2013).","journal-title":"PLoS One"},{"key":"30229_CR10","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1086\/509894","volume":"195","author":"S Livingston","year":"2007","unstructured":"Livingston, S. et al. Hepatitis B virus genotypes in Alaska Native people with hepatocellular carcinoma: preponderance of genotype F. J Infect Dis. 195, 5\u201311 (2007).","journal-title":"J Infect Dis."},{"key":"30229_CR11","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s11262-008-0261-x","volume":"37","author":"M von Meltzer","year":"2008","unstructured":"von Meltzer, M. et al. A new clade of hepatitis B virus subgenotype F1 from Peru with unusual properties. Virus Genes. 37, 225\u2013230 (2008).","journal-title":"Virus Genes."},{"key":"30229_CR12","doi-asserted-by":"publisher","first-page":"e1005602","DOI":"10.1371\/journal.pgen.1005602","volume":"11","author":"J Homburger","year":"2015","unstructured":"Homburger, J. et al. Genomic insights into the ancestry and demographic history of South America. PLoS genetics 11, e1005602 (2015).","journal-title":"PLoS genetics"},{"key":"30229_CR13","unstructured":"Chan, A. et al. Early-age hepatocellular carcinoma associated with hepatitis B infection in South America. Clin Gastroenterol Hepatol (2017)."},{"key":"30229_CR14","doi-asserted-by":"publisher","first-page":"e114912","DOI":"10.1371\/journal.pone.0114912","volume":"9","author":"A Marchio","year":"2014","unstructured":"Marchio, A. et al. A peculiar Mutation Spectrum emerging from young Peruvian Patients with Hepatocellular Carcinomas. PLOS One 9, e114912 (2014).","journal-title":"PLOS One"},{"key":"30229_CR15","doi-asserted-by":"crossref","unstructured":"Nault, J. et al. High frequency of telomerase reverse-transcriptase promoter somatic mutations in hepatocellular carcinoma and preneoplastic lesions. Nat Commun 4 (2013).","DOI":"10.1038\/ncomms3218"},{"key":"30229_CR16","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1002\/hep.29463","volume":"67","author":"B Halgand","year":"2018","unstructured":"Halgand, B. et al. Hepatitis B Virus Pregenomic RNA in Hepatocellular Carcinoma: A Nosological and Prognostic Determinant. Hepatology 67, 86\u201396 (2018).","journal-title":"Hepatology"},{"key":"30229_CR17","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1006\/geno.1995.9004","volume":"29","author":"M Minami","year":"1995","unstructured":"Minami, M., Poussin, K., Brechot, C. & Paterlini, P. A novel PCR technique using Alu-specific primers to identify unknown flanking sequences from the human genome. Genomics 29, 403\u2013408 (1995).","journal-title":"Genomics"},{"key":"30229_CR18","first-page":"201","volume":"57","author":"S Alavian","year":"2013","unstructured":"Alavian, S., Carman, W. & Jazayeri, S. HBsAg variants: Diagnostic-escape and diagnostic dilemma. 57, 201\u2013208 (2013).","journal-title":"HBsAg variants: Diagnostic-escape and diagnostic dilemma."},{"key":"30229_CR19","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1093\/jnci\/djp180","volume":"101","author":"S Liu","year":"2009","unstructured":"Liu, S. et al. Associations between hepatitis B virus mutations and the risk of hepatocellular carcinoma: a meta-analysis. J Natl Cancer Inst 101, 1066\u20131082 (2009).","journal-title":"J Natl Cancer Inst"},{"key":"30229_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1365-2893.2009.01245.x","volume":"17","author":"F Hollinger","year":"2010","unstructured":"Hollinger, F. & Good, S. Occult hepatitis B virus infection: a covert operation. J Viral Hepat 17, 1\u201315 (2010).","journal-title":"J Viral Hepat"},{"key":"30229_CR21","doi-asserted-by":"publisher","first-page":"S72","DOI":"10.1002\/hep.22884","volume":"49","author":"C Chen","year":"2009","unstructured":"Chen, C., Yang, H. & Iloeje, U. Hepatitis B virus DNA levels and outcomes in chronic hepatitis B. Hepatology 49, S72\u2013S84 (2009).","journal-title":"Hepatology"},{"key":"30229_CR22","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1002\/hep.23464","volume":"51","author":"J Simonetti","year":"2010","unstructured":"Simonetti, J. et al. Clearance of hepatitis B surface antigen and risk of hepatocellular carcinoma in a cohort chronically infected with hepatitis B virus. Hepatology 51, 1531\u20131537 (2010).","journal-title":"Hepatology"},{"key":"30229_CR23","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1001\/jama.295.1.65","volume":"295","author":"C Chen","year":"2006","unstructured":"Chen, C. et al. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA 295, 65\u201373 (2006).","journal-title":"JAMA"},{"key":"30229_CR24","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1177\/1756283X17710247","volume":"10","author":"C Shim","year":"2017","unstructured":"Shim, C. et al. Noncirrhotic hepatocellular carcinoma: etiology and occult hepatitis B virus infection in a hepatitis B virus-endemic area. Therap Adv Gastroenterol. 10, 529\u2013536 (2017).","journal-title":"Therap Adv Gastroenterol."},{"key":"30229_CR25","doi-asserted-by":"publisher","first-page":"6252","DOI":"10.3748\/wjg.v20.i20.6252","volume":"20","author":"W Liu","year":"2014","unstructured":"Liu, W. & Liu, Q. Molecular mechanisms of gender disparity in hepatitis B virus-associated hepatocellular carcinoma. World J Gastroenterol 20, 6252\u20136261 (2014).","journal-title":"World J Gastroenterol"},{"key":"30229_CR26","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.jhep.2006.10.007","volume":"46","author":"G Raimondo","year":"2007","unstructured":"Raimondo, G., Pollicino, T., Cacciola, I. & Squadrito, G. Occult hepatitis B virus infection. J Hepatol 46, 160\u2013170 (2007).","journal-title":"J Hepatol"},{"key":"30229_CR27","doi-asserted-by":"publisher","first-page":"7181","DOI":"10.3748\/wjg.v20.i23.7181","volume":"20","author":"S Roman","year":"2014","unstructured":"Roman, S. et al. Hepatitis B virus infection in Latin America: a genomic medicine approach. World J Gastroenterol 20, 7181\u20137196 (2014).","journal-title":"World J Gastroenterol"},{"key":"30229_CR28","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1590\/S0100-879X2006005000197","volume":"41","author":"R Alencar","year":"2008","unstructured":"Alencar, R. et al. Low occurrence of occult hepatitis B virus infection and high frequency of hepatitis C virus genotype 3 in hepatocellular carcinoma in Brazil. Braz J Med Biol Res 41, 235\u2013240 (2008).","journal-title":"Braz J Med Biol Res"},{"key":"30229_CR29","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1590\/S0004-28032007000100013","volume":"44","author":"F Branco","year":"2007","unstructured":"Branco, F. et al. Occult hepatitis B virus infection in patients with chronic liver disease due to hepatitis C virus and hepatocellular carcinoma in Brazil. Arq Gastroenterol 44, 58\u201363 (2007).","journal-title":"Arq Gastroenterol"},{"key":"30229_CR30","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1590\/0074-0276140058","volume":"109","author":"G Escobedo-Melendez","year":"2014","unstructured":"Escobedo-Melendez, G., Panduro, A., Fierro, N. & Roman, S. High prevalence of occult hepatitis B virus genotype H infection among children with clinical hepatitis in west Mexico. Mem Inst Oswaldo Cruz 109, 728\u2013737 (2014).","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"30229_CR31","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1007\/s12072-008-9112-z","volume":"3","author":"B McMahon","year":"2009","unstructured":"McMahon, B. The influence of hepatitis B virus genotype and subgenotype on the natural history of chronic hepatitis B. Hepatol Int 3, 334\u2013342 (2009).","journal-title":"Hepatol Int"},{"key":"30229_CR32","doi-asserted-by":"publisher","first-page":"5446","DOI":"10.3748\/wjg.v19.i33.5446","volume":"19","author":"S Roman","year":"2013","unstructured":"Roman, S. & Panduro, A. HBV endemicity in Mexico is associated with HBV genotypes H and G. World J Gastroenterol 19, 5446\u20135453 (2013).","journal-title":"World J Gastroenterol"},{"key":"30229_CR33","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.mrfmmm.2004.06.057","volume":"571","author":"G Pfeifer","year":"2005","unstructured":"Pfeifer, G., You, Y. & Besaratinia, A. Mutations induced by ultraviolet light. Mutat Res 571, 19\u201331 (2005).","journal-title":"Mutat Res"},{"key":"30229_CR34","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S0027-5107(99)00005-6","volume":"424","author":"D Lloyd","year":"1999","unstructured":"Lloyd, D. & Phillips, D. Oxidative DNA damage mediated by copperII\/, ironII\/ and nickelII\/ Fenton reactions: evidence for site-specific mechanisms in the formation of double-strand breaks, 8 hydroxydeoxyguanosine and putative intrastrand cross-links. Mut Res 424, 23\u201336 (1999).","journal-title":"Mut Res"},{"key":"30229_CR35","doi-asserted-by":"publisher","first-page":"5749","DOI":"10.1073\/pnas.88.13.5749","volume":"88","author":"A Carothers","year":"1991","unstructured":"Carothers, A., Mucha, J. & Grunberger, D. DNA strand-specific mutations induced by (+)-3a,4.6-dihydroxy-1a,2a-epoxy-1,2,3,4-tetrahydrobenzo[c] phenanthrene in the dihydrofolate reductase gene. Proc Natl Acad Sci USA 88, 5749\u20135753 (1991).","journal-title":"Proc Natl Acad Sci USA"},{"key":"30229_CR36","doi-asserted-by":"publisher","first-page":"3131","DOI":"10.18632\/aging.101120","volume":"8","author":"A Guedj","year":"2016","unstructured":"Guedj, A. et al. Early age decline in DNA repair capacity in the liver: in depth profile of differential gene expression. Aging (Albany NY) 8, 3131\u20133146 (2016).","journal-title":"Aging (Albany NY)"},{"key":"30229_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2164-14-736","volume":"14","author":"H Wang","year":"2013","unstructured":"Wang, H. et al. Forfeited hepatogenesis program and increased embryonic stem cell traits in young hepatocellular carcinoma (HCC) comparing to elderly HCC. BMC Genomics. 14, 736 (2013).","journal-title":"BMC Genomics."},{"key":"30229_CR38","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1111\/j.1365-2893.2006.00780.x","volume":"14","author":"F Tsai","year":"2007","unstructured":"Tsai, F. et al. Lower serum viral loads in young patients with hepatitis-B-virus-related hepatocellular carcinoma. J Viral Hepat 14, 153\u2013160 (2007).","journal-title":"J Viral Hepat"},{"key":"30229_CR39","doi-asserted-by":"publisher","first-page":"e00052","DOI":"10.1016\/j.heliyon.2015.e00052","volume":"2","author":"E Ruiz","year":"2016","unstructured":"Ruiz, E. et al. Hepatocellular carcinoma surgery outcomes in the developing world: A 20-year retrospective cohort study at the National Cancer Institute of Peru. Heliyon 2, e00052 (2016).","journal-title":"Heliyon"},{"key":"30229_CR40","unstructured":"Bosman, F., Carneiro, F., Hruban, R. & Theise, N. WHO classification of tumours of the digestive system. 4th edn, (IARC Press, 2010)."},{"key":"30229_CR41","doi-asserted-by":"publisher","first-page":"e1004343","DOI":"10.1371\/journal.ppat.1004343","volume":"10","author":"A Ducroux","year":"2014","unstructured":"Ducroux, A. et al. The Tudor domain protein Spindlin1 is involved in intrinsic antiviral defense against incoming hepatitis B Virus and herpes simplex virus type 1. PLoS pathogens 10, e1004343 (2014).","journal-title":"PLoS pathogens"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-30229-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-30229-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-30229-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T08:36:01Z","timestamp":1671611761000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-30229-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,13]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["30229"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-30229-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,13]]},"assertion":[{"value":"23 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"12031"}}